Acro Biomedical (ACBM) Research & Development (2021 - 2023)

Acro Biomedical's Research & Development history runs 3 years deep, the most recent figure standing at $396550.0 for Q3 2023.

• In Q3 2023, Research & Development fell 84.26% year-over-year to $396550.0; the TTM figure through Jun 2024 stood at $396550.0 (down 95.8% YoY), while the FY2023 annual figure was $4.8 million, down 52.43% from the prior year.
• Research & Development was $396550.0 for Q3 2023 at Acro Biomedical, down from $1.9 million in the prior quarter.
• In the past five years, Research & Development ranged from a high of $2.5 million in Q4 2021 to a low of $396550.0 in Q3 2023.
• Historically, Research & Development has averaged $2.0 million across 3 years, with a median of $2.5 million in 2021.
• The sharpest annual moves came in 2022 and 2023: Research & Development surged 292.69% in 2022, then sank 84.26% in 2023.
• A 3-year view of Research & Development shows it stood at $2.5 million in 2021, then changed by 0.0% to $2.5 million in 2022, then tumbled by 84.26% to $396550.0 in 2023.
• The last three Research & Development figures came in at $396550.0 (Q3 2023), $1.9 million (Q2 2023), and $2.5 million (Q1 2023), per Business Quant data.